Tag: medical skincare

  • A Korean Derma Brand With Eight Decades of Heritage JOGABI CEO Park Min-jae

    A Korean Derma Brand With Eight Decades of Heritage JOGABI CEO Park Min-jae

    JOGABI traces its origins to ointment dispensed in shells in 1943 and cites 80 years of accumulated clinical data. We met CEO Park Min-jae to discuss the Korean derma brand’s approach to skin across generations

    Q How did JOGABI’s 80-year history begin?

    I am Park Min-jae, CEO of medical skincare brand JOGABI. It is meaningful to speak with salon directors and readers who work closely with clients’ skin. JOGABI combines more than 80 years of skin-related knowledge with contemporary biotechnology. Its history dates to 1943. During the difficult years of Japanese colonial rule and war, my maternal grandfather, Dr. Jeong Gwang-hun, prepared ointment for people with skin diseases. Containers were scarce. He collected river shells beyond Sangdo-dong at dawn, then washed and dried them to hold the ointment. Word of mouth spread across Korea, giving rise to Ewha Jogaebi. Ewha Pharmacy subsequently opened and formally supplied the ointment. The small shells carried by departing patients became the origin and symbol of JOGABI.

    Q What distinguishes the brand’s approach, inherited from Ewha Dermatology?

    “Diagnostic data grounded in more than 80 years of medical practice combined with patented ingredients and formulation technology”

    Two factors underpin the brand’s position. The first is diagnostic data accumulated over more than 80 years, alongside patented ingredients and formulation technology. Rather than following trends, JOGABI draws on hundreds of thousands of skin-related clinical records from Ewha Pharmacy and Ewha Dermatology. The source reports approximately three million cumulative patients at Ewha Dermatology, among Korea’s highest totals according to medical-association figures. It also cites JCI accreditation, describing the system as internationally recognized and acknowledged by the World Health Organization. These records inform our understanding of sensitive skin, ingredient suitability, and contributing factors in blemish-prone skin. This accumulated experience cannot be reproduced quickly. The second factor is attention to formulation detail. We consider ingredients to include or exclude for specific skin types and concerns, alongside texture, spreadability, persistence, temperature, and pH. Products use highly purified raw materials and reflect principles maintained over many years. We believe this consistency builds confidence among clients seeking medical skincare for challenging skin concerns.

    Q What defines a good cosmetic, and what matters most during development?

    “A carefully balanced formulation designed with safety in mind”

    Skin concerns can affect more than appearance; they may influence overall quality of life. A good cosmetic must suit the person using it. We pursue performance alongside safety, asking about suitability for sensitive skin before considering effectiveness alone. We devote substantial development time to ingredient ratios informed by our accumulated clinical data. Cosmetics differ from medicines and generally do not deliver immediate therapeutic effects. Consistent use of suitable ingredients is central to our approach to maintaining skin condition. This explains why the entire range focuses on the skin barrier and soothing. We remember Jeong’s original purpose in dispensing ointment in shells and develop products with users’ skin-related distress in mind.

    Q Which products best represent the brand’s performance in practice?

    Renew Peel Cleanser records the strongest sales within our range. We regard its combination of daily cleansing and exfoliation as a distinctive category in Korea. Its central mechanism involves what we describe as nano-sized amino acids derived from finely broken-down protein. They are intended to adsorb impurities and dead skin cells selectively. This differs from indiscriminate physical or chemical exfoliation in the formulation’s stated rationale. PHA adds hydration and mild exfoliation for a hydrated finish. Repeated irritation assessments during development supported its intended daily-use positioning. The source instructs cleansing with warm water and shaking the container thoroughly before application. The single 130 ml size was deliberately chosen to maintain ingredient freshness.

    Refine Cell Boost receives particularly strong feedback in professional esthetics. These ampoules were developed for professional treatments. Refine P137™ combines 13 vitamins and antioxidant ingredients for radiance-focused care. Refine C410™ uses nanodispersion technology intended to support absorption of active ingredients. Mixing the two in a 1:1 ratio is especially popular in salon cocktail programs. Directors report immediate changes in the appearance of fullness, leading to the nickname God Care.

    Q What support accompanies introduction of JOGABI into salons?

    Introducing JOGABI provides access to our accumulated practice knowledge as well as products. We support partners through several channels. Salons with designated agreements receive specialist training through JOGABI Medical Academy. Drawing on Ewha Dermatology’s records, teaching covers skin assessment and personalized cocktail-therapy techniques alongside product application. Our goal is to help less-experienced directors develop case-based expertise. Marketing support includes storytelling materials, social media content, and signs explaining the brand’s heritage. We aim to support consistent practice and stable salon operations through this partnership.

    Q What are the brand’s next steps?

    I hope JOGABI is remembered for consistent principles and practical results rather than conspicuous marketing or passing trends. We aim to provide a dependable place within skincare across generations. Continued research, development, and assessment should establish the brand as a Korean derma reference. Combining Ewha Dermatology’s records with contemporary biotechnology remains central to our work for problem-prone and uncomfortable skin. At the time of this interview, Atoloop Cream and Mist were planned for launch in May–June. This premium range is intended for children and adults. Export arrangements with a Japanese distributor had been completed, while discussions covered the United States, China, and Vietnam. We believe carefully developed Korean formulations and the history of ointment dispensed in shells can also connect with international audiences. Our aim is to carry that original concern for skin wellbeing beyond Korea.

    Editor GAHEE, BAEK
    Image Shutterstock
    The Signature Magazine – May 2026 Issue